Fundraising Fox
/People
Sign in

Liam Ratcliffe

Investor

Head of Biotechnology at Access Biotechnology · General Partner at New Leaf Venture Partners · Head of Biotechnology at Access Industries · Vice President, Human Genetics at 23andMe · Board director at Eliem Therapeutics · +2 more

New York, New York, United States

Writes $100K – $5M checks · typically $1.5M

Find your path to Liam

180 people in our graph can introduce you to Liam.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Pierre-Eric Leibovici to introduce you to Liam

You →Pierre-Eric · together at 23andMe (2020–2026) →Liam

Ask Jamie Chen to introduce you to Liam

You →Jamie · 11 people · together at 23andMe →Liam

Sign up to find every way you can get introduced to Liam

  • Your email: the people you already email who know Liam
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Liam
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Head of Access Biotechnology and former head of worldwide clinical R&D at Pfizer.

Invests in

Biotech

Board director at Eliem Therapeutics

Intro paths

→

In turn, Liam can intro founders to Eliem Therapeutics's investors below.

Eliem Therapeutics's investors · 6

Access BiotechnologyNew York · since 2021ACORN BIOVENTURESNew York · since 2021Intermediate Capital GroupLondon · $5M – $50M checks · since 2021LifeArc VenturesLondon · since 2021Manta Ray VenturesLondonRA CapitalBoston · since 2021

Manager at Halda Therapeutics

Intro paths

→

In turn, Liam can intro founders to Halda Therapeutics's investors below.

Halda Therapeutics's investors · 8

Access BiotechnologyNew YorkCanaan PartnersStamford · $500K – $20M checks · since 2019Connecticut InnovationsNew Haven · $500K – $2M checksElm Street VenturesNew Haven · $250K – $1M checksFrazier Life SciencesPalo AltoRA CapitalBostonTaiho Ventures, LLCMenlo ParkVida VenturesLos Angeles · since 2024

Director at CuraSen Therapeutics

Intro paths

→

In turn, Liam can intro founders to CuraSen Therapeutics's investors below.

CuraSen Therapeutics's investors · 9

abrdn plcEdinburghAlta PartnersJackson · $1M – $12M checks · since 2018Chiesi VenturesBoston · $5M checksIntermediate Capital GroupLondon · $5M – $50M checksJohnson & Johnson Innovation – JJDCNew BrunswickLongitude CapitalMenlo Park · $10M – $30M checks · since 2018New Leaf Venture PartnersNew York · since 2018Pappas CapitalDurhamPappas CapitalResearch Triangle Park · $100K – $6M checks · since 2018

Co-founders at CuraSen Therapeutics

AP
Anthony P. FordExecutive Officer, Director

Experience

  1. Access IndustriesHead of Biotechnologycurrent2019 — presentGreater New York City Area
  2. New Leaf Venture PartnersManaging Director2013 — 2019
  3. New Leaf Venture PartnersGeneral Partner2008 — 2019
  4. Pfizer IncSnr VP, Pfizer Global Research and Development1996 — 2008

Skills & more

Biopharmaceuticals13Biotechnology67

From Liam's professional profile.

Colleagues at Access Biotechnology

Christine Borowski
Vice President at Access Biotechnology
Dan Becker
Managing Director at Access Biotechnology

Network3

Adam M. KoppelScout
Managing Director at Bain Capital Life Sciences
Bruce ClevelandScout
Partner at Wildcat Venture Partners
Carl L. GordonScout
Managing Partner at OrbiMed

Investors connected to Liam in public investor directories — a warm-intro map.

Frequently asked questions

Who is Liam Ratcliffe?
Head of Access Biotechnology and former head of worldwide clinical R&D at Pfizer.
Where does Liam Ratcliffe work?
Liam Ratcliffe is Head of Biotechnology at Access Biotechnology and Board director at Eliem Therapeutics and Manager at Halda Therapeutics.
What does Liam Ratcliffe invest in?
Liam Ratcliffe invests in Biotech.
What check size does Liam Ratcliffe write?
Liam Ratcliffe typically writes checks of $100K – $5M.
Where did Liam Ratcliffe go to school?
Liam Ratcliffe studied at University of Michigan - Stephen M. Ross School of Business (MBA); University of Cape Town (PhD, immunology); University of Cape Town (MBChB, Medicine).

Same school

Shared employers